Stocks in Focus : Sarepta Therapeutics (NASDAQ:SRPT), Google Inc (NASDAQ:GOOGL), B&G Foods Inc. (NYSE:BGS), Repros Therapeutics Inc. (NASDAQ:RPRX), Tejon Ranch (NYSE:TRC)

Technology Stocks News 5

Chris Garabedian, President and CEO Sarepta Therapeutics, Inc. (NASDAQ:SRPT), announced that the Phase IIb clinical study on its first product, eteplirsen, will have its results submitted to the FDA by the end of the year, with a launch slated for mid next-year if approved. He was speaking at the Canaccord Genuity 34th Annual Growth Conference at the Intercontinental Hotel in Boston, Massachusetts. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) belongs to Healthcare sector. Its weekly performance is 4.68%. On last trading day company shares ended up $22.36. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) distance from 50-day simple moving average (SMA50) is -13.00%.

Google Inc (NASDAQ:GOOGL) is launching an ad-free subscription-based YouTube service, according to leaked screenshots, the latest step in the evolution of media consumption from the traditional tube to online and mobile. Google Inc (NASDAQ:GOOGL) shares moved up 0.74% in last trading session and ended the day at $597.11. GOOGL Gross Margin is 58.90% and its return on assets is 11.60%. Google Inc (NASDAQ:GOOGL) quarterly performance is 10.50%.

B&G Foods Inc. (NYSE:BGS) is pleased to announce a tasty transformation of the original melba toast brand, Old London®. The relaunch of Old London Melba features sophisticated and colorful new packaging, contemporary flavors and an easy approach to everyday eating and entertaining. Old London Melba is also unveiling a partnership with Lisa Lillien (a.k.a. Hungry Girl), a go-to resource for guilt-free eating, as well as new product offering, Old London Melba Toasts Ancient Grains. On 19 August, B&G Foods Inc. (NYSE:BGS) shares moved up 0.52% and was closed at $29.19. BGS EPS growth in last 5 year was 29.40%. B&G Foods Inc. (NYSE:BGS) year to date (YTD) performance is -12.05%.

Repros Therapeutics (NASDAQ:RPRX) CFO Katherine Anderson bought 2,000 shares of Repros Therapeutics stock on the open market in a transaction dated Thursday, August 14th. The stock was purchased at an average price of $13.85 per share, with a total value of $27,700.00. Repros Therapeutics Inc. (NASDAQ:RPRX) ended the last trading day at $14.83. Company weekly volatility is calculated as 4.10%and price to cash ratio as 5.04. Repros Therapeutics Inc. (NASDAQ:RPRX) showed a weekly performance of 6.08%.

Tejon Ranch (NYSE:TRC) VP Joseph E. Drew unloaded 2,000 shares of Tejon Ranch stock on the open market in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $28.12, for a total value of $56,240.00. Following the completion of the transaction, the vice president now directly owns 72,206 shares of the company’s stock, valued at approximately $2,030,433. The transaction was disclosed in a legal filing with the Securities & Exchange Commission. Tejon Ranch Co. (NYSE:TRC) shares moved down -0.67% in last trading session and ended the day on $28.36. TRC Gross Margin is 26.50% and its return on assets is 1.40%. Tejon Ranch Co. (NYSE:TRC) quarterly performance is -6.83%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone